219 related articles for article (PubMed ID: 16639693)
41. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
Harjunpää A; Taskinen M; Nykter M; Karjalainen-Lindsberg ML; Nyman H; Monni O; Hemmer S; Yli-Harja O; Hautaniemi S; Meri S; Leppä S
Br J Haematol; 2006 Oct; 135(1):33-42. PubMed ID: 16925574
[TBL] [Abstract][Full Text] [Related]
42. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
Møller MB; Pedersen NT; Christensen BE
Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
[TBL] [Abstract][Full Text] [Related]
43. Absolute lymphocyte count predicts overall survival in follicular lymphomas.
Siddiqui M; Ristow K; Markovic SN; Witzig TE; Habermann TM; Colgan JP; Inwards DJ; White WL; Ansell SM; Micallef IN; Johnston PB; Call TG; Porrata LF
Br J Haematol; 2006 Sep; 134(6):596-601. PubMed ID: 16889618
[TBL] [Abstract][Full Text] [Related]
44. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Marcus R; Imrie K; Solal-Celigny P; Catalano JV; Dmoszynska A; Raposo JC; Offner FC; Gomez-Codina J; Belch A; Cunningham D; Wassner-Fritsch E; Stein G
J Clin Oncol; 2008 Oct; 26(28):4579-86. PubMed ID: 18662969
[TBL] [Abstract][Full Text] [Related]
45. BNIP3 expression in follicular lymphoma.
Sington J; Giatromanolaki A; Campo L; Turley H; Pezzella F; Gatter KC
Histopathology; 2007 Apr; 50(5):555-60. PubMed ID: 17394490
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
47. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
[TBL] [Abstract][Full Text] [Related]
48. bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow.
Cook JR; Craig FE; Swerdlow SH
Am J Clin Pathol; 2003 Jan; 119(1):145-51. PubMed ID: 12520710
[TBL] [Abstract][Full Text] [Related]
49. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
50. [Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma].
Katzenberger T; Lohr A; Ott MM; Kalla J; Rosenwald A; Müller-Hermelink HK; Ott G
Verh Dtsch Ges Pathol; 2000; 84():153-61. PubMed ID: 11217435
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometric evaluation of CD38 expression assists in distinguishing follicular hyperplasia from follicular lymphoma.
Mantei K; Wood BL
Cytometry B Clin Cytom; 2009 Sep; 76(5):315-20. PubMed ID: 19382196
[TBL] [Abstract][Full Text] [Related]
52. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
53. Follicular lymphomas.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Jun; 66(3):248-61. PubMed ID: 18359244
[TBL] [Abstract][Full Text] [Related]
54. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
55. Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
Sohani AR; Maurer MJ; Giri S; Pitcher B; Chadburn A; Said JW; Bartlett NL; Czuczman MS; Martin P; Rosenbaum CA; Jung SH; Leonard JP; Cheson BD; Hsi ED
Am J Surg Pathol; 2021 Mar; 45(3):384-393. PubMed ID: 33136585
[TBL] [Abstract][Full Text] [Related]
56. Re: Torlakovic et al. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor. J Pathol 2005;206:312-319.
Wang X; Ding BB; Mendez LM; Papetti M; Ye BH
J Pathol; 2006 Sep; 210(1):130-1; author reply 132. PubMed ID: 16841370
[No Abstract] [Full Text] [Related]
57. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
Wahlin BE; Sander B; Christensson B; Kimby E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
[TBL] [Abstract][Full Text] [Related]
58. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Canioni D; Salles G; Mounier N; Brousse N; Keuppens M; Morchhauser F; Lamy T; Sonet A; Rousselet MC; Foussard C; Xerri L
J Clin Oncol; 2008 Jan; 26(3):440-6. PubMed ID: 18086798
[TBL] [Abstract][Full Text] [Related]
59. Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
[TBL] [Abstract][Full Text] [Related]
60. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
